Fighting Coronavirus Donate
Fighting Coronavirus Donate
About Us tri
About Us Overview
About Us

Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.

Our Achievements tri
Our Achievements Overview
Our Achievements

The Weizmann Institute’s fundamental research has led to discoveries and applications with a major impact on the scientific community and on the quality of life for millions worldwide.

Get Involved tri
Get Involved Overview
Get Involved

Join a community of dedicated people who share the Weizmann Institute’s commitment to shaping a better world through science.

News & Media tri
News & Media Overview
News & Media

Learn about the Weizmann Institute’s latest groundbreaking discoveries and the American Committee’s activities across the country.

Blog tri
Blog

Popular science for the curious-minded: The Curiosity Review brings discovery to life.

Contact

CORONAVIRUS

What is Weizmann Doing?

This special coronavirus section shares Weizmann Institute of Science research, expert opinion, education resources, and news. Our scientists are already conducting investigations that could improve testing and diagnosis techniques and provide new strategies for prevention and treatment. We are committed to advancing research to protect and preserve the health and well-being of everyone, everywhere.

Learn more about our fight against Coronavirus

Coronavirus
Israeli Scientists Think They Know Why Virus is Severe for Some, Mild for Others
The Times of Israel
Prof. Ido Amit’s team is showing why COVID affects people so differently, reports The Times of Israel. The work could help pharmaceutical firms develop drugs by “providing a ‘target’ in the body for intervention.”

May 14, 2020
Coronavirus
Experts Find Link to Contracting Coronavirus and Socioeconomic Status
The Jerusalem Post
Prof. Eli Waxman heads a team that found people with less income and education are more likely to get COVID, reports The Jerusalem Post. The group advises Netanyahu on coronavirus.

May 13, 2020
Coronavirus
This Twist on the Four-Day Workweek Could Get People Back to Work Without Causing New Outbreaks
Fast Company
Fast Company covers the reopening strategy proposed by Prof. Uri Alon and Prof. Ron Milo, who says: “Our suggestion gives a predictable schedule that people can adapt to and builds confidence for people and the economy.”

May 12, 2020
Coronavirus
10-4: How to Reopen the Economy by Exploiting the Coronavirus’s Weak Spot
The New York Times
Profs. Uri Alon and Ron Milo write in The New York Times about their intermittent-work strategy to reopen society.

May 11, 2020
Coronavirus
Israeli Researchers Pinpoint What Happens to Seriously Ill Coronavirus Patients
Haaretz
As Haaretz reports, Prof. Ido Amit has found that the immune system plays a role in why some people get much sicker from COVID. He is now developing clinical studies to try and protect patients.

May 11, 2020
Coronavirus
How Often Do COVID-19 Patients Lose Their Sense of Smell? Two Studies Are Tracking Down the Data
Discover
Discover covers two studies – including Prof. Noam Sobel’s research – that are investigating how often people with COVID lose their sense of smell. The studies are seeking participants to take online tests.

May 11, 2020
Coronavirus
Maintaining Public Health Should not Mean the Death of Privacy, Says Turing Award Winner
CTECH
In this interview with CTECH, Prof. Shafi Goldwasser, who developed a tracking technology, talks about how important it is to monitor COVID’s spread—without violating individual privacy.

May 09, 2020
Coronavirus
COVID Moonshot: Can AI Algorithms and Volunteer Chemists Design a Knockout Antiviral?
IEEE Spectrum
Dr. Nir London helps head the “COVID Moonshot,” which involves academics, researchers, private firms, and the public, all working together on a coronavirus treatment. IEEE Spectrum reports.

May 08, 2020
Coronavirus
Could the Flu Become History? An Israeli Vaccine May Make It a Reality
Haaretz Magazine
Haaretz Magazine interviews Prof. Ruth Arnon, whose universal flu vaccine is on the cusp of approval. The vaccine will protect against multiple strains of flu for years with one shot, and is almost through clinical trials.

May 06, 2020
SHARE
About Us
Our Achievements
Get Involved
News & Media Blog: Curiosity Review Fighting Coronavirus Donate Now Contact Us
Privacy Policy Gift Acceptance Policy Financial Information

©2022 American Committee for the Weizmann Institute of Science

FOR THE FOURTH CONSECUTIVE YEAR